Irreversible electroporation (IRE) is a nonthermal ablation technique that is used clinically in
selected patients with locally advanced pancreatic cancer, but most patients develop …

Simple Summary Pancreatic ductal adenocarcinoma (PDAC) is a devastating malignancy
with a poor prognosis and a dismal survival rate. Oncolytic virus (OV) is an anticancer …

Background Systemic immunotherapy has had limited clinical benefit in pancreatic ductal
adenocarcinoma. This is thought to be due to its desmoplastic immunosuppressive tumor …

Background Pancreatic cancer (PC) has a poor prognosis, and most patients present with
either locally advanced or distant metastatic disease. Irreversible electroporation (IRE) is a …

Background We describe the use of pancreatic retrograde venous infusion in an orthotopic
murine model of pancreatic ductal adenocarcinoma and hypothesize that pancreatic …

Purpose There is a great need to reduce the toxicity of chemotherapy used in the
management of pancreatic ductal adenocarcinoma (PDAC). Here we explore if regional …

Improvement of outcome in patients with pancreatic ductal adenocarcinoma (PDAC)
requires exploration of novel therapeutic targets. Thus far, most studies of PDAC therapies …

Pancreatic cancer is currently the seventh leading cause of cancer death (4.5% of all cancer
deaths) while 80%-90% of the patients suffer from unresectable disease at the time of …

In the last two years, the percentage of cases in Peru linked to diarrheal diseases in children
has been considerably reduced, demonstrating that even in difficult times health must …